Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 2
2005 7
2006 4
2007 5
2008 16
2009 3
2010 5
2011 15
2012 11
2013 10
2014 11
2015 9
2016 7
2017 13
2018 7
2019 3
2020 11
2021 13
2022 12
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees. McMurray JJ, et al. N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30. N Engl J Med. 2014. PMID: 25176015 Free article. Clinical Trial.
Editorial: Tropical fungal diseases.
Taborda CP, Muñoz JE, Gonzalez A. Taborda CP, et al. Among authors: gonzalez a. Front Cell Infect Microbiol. 2022 Dec 29;12:1104519. doi: 10.3389/fcimb.2022.1104519. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36644771 Free PMC article. No abstract available.
Editorial: Pathogenesis of Dimorphic Fungal Infections.
Gonzalez A, Taborda CP. Gonzalez A, et al. Front Cell Infect Microbiol. 2021 Nov 11;11:793245. doi: 10.3389/fcimb.2021.793245. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34858884 Free PMC article. No abstract available.
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators. McMurray JJ, et al. Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5. Eur J Heart Fail. 2013. PMID: 23563576 Free PMC article. Clinical Trial.
176 results